Form 8-K - Current report:
SEC Accession No. 0001213900-24-092389
Filing Date
2024-10-31
Accepted
2024-10-30 18:32:52
Documents
15
Period of Report
2024-10-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0219282-8k_klotho.htm   iXBRL 8-K 28284
2 EMPLOYMENT AGREEMENT ea021928201ex10-1_klotho.htm EX-10.1 86846
  Complete submission text file 0001213900-24-092389.txt   356804

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE kltow-20241024.xsd EX-101.SCH 3502
4 XBRL DEFINITION FILE kltow-20241024_def.xml EX-101.DEF 26521
5 XBRL LABEL FILE kltow-20241024_lab.xml EX-101.LAB 36430
6 XBRL PRESENTATION FILE kltow-20241024_pre.xml EX-101.PRE 25145
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0219282-8k_klotho_htm.xml XML 5485
Mailing Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010
Business Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010 646-916-5315
Klotho Neurosciences, Inc. (Filer) CIK: 0001907223 (see all company filings)

EIN.: 862727441 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41340 | Film No.: 241411833
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)